Literature DB >> 20098797

[Homeostasis model assessment (HOMA) values in Chilean elderly subjects].

María Luisa Garmendia1, Lydia Lera, Hugo Sánchez, Ricardo Uauy, Cecilia Albala.   

Abstract

BACKGROUND: The homeostasis assessment model for insulin resistance (HOMA-IR) estimates insulin resistance using basal insulin and glucose values and has a good concordance with values obtained with the euglycemic clamp. However it has a high variability that depends on environmental, genetic and physiologic factors. Therefore it is imperative to establish normal HOMA values in different populations. AIM: To report HOMA-IR values in Chilean elderly subjects and to determine the best cutoff point to diagnose insulin resistance.
MATERIAL AND METHODS: Cross sectional study of 1003 subjects older than 60 years of whom 803 (71% women) did not have diabetes. In 154 subjects, an oral glucose tolerance test was also performed. Insulin resistance (IR) was defined as the HOMA value corresponding to percentile 75 of subjects without over or underweight. The behavior of HOMA-IR in metabolic syndrome was studied and receiver operating curves (ROC) were calculated, using glucose intolerance defined as a blood glucose over 140 mg/dl and hyperinsulinemia, defined as a serum insulin over 60 microU/ml, two hours after the glucose load.
RESULTS: Median HOMA-IR values were 1.7. Percentile 75 in subjects without obesity or underweight was 2.57. The area under the ROC curve, when comparing HOMA-IR with glucose intolerance and hyperinsulinemia, was 0.8 (95% confidence values 0.72-0.87), with HOMA-IR values ranging from 2.04 to 2.33.
CONCLUSIONS: HOMA-IR is a useful method to determine insulin resistance in epidemiological studies. The HOMA-IR cutoff point for insulin resistance defined in thi spopulation was 2.6.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098797     DOI: /S0034-98872009001100001

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  6 in total

1.  Genetic and Non-Genetic Determinants of Circulating Levels of Adiponectin in a Cohort of Chilean Subjects.

Authors:  Fernando Lanas; Pamela Serón; Nicolás Saavedra; Jenny Ruedlinger; Luis Salazar
Journal:  Mol Diagn Ther       Date:  2015-08       Impact factor: 4.074

2.  Comparison of adipokines in a cross-sectional study with healthy overweight, insulin-sensitive and healthy lean, insulin-resistant subjects, assisted by a family doctor primary care program.

Authors:  Samuel D Moscavitch; Hye C Kang; Rubens A C Filho; Evandro T Mesquita; Hugo C C F Neto; Maria L G Rosa
Journal:  Diabetol Metab Syndr       Date:  2016-02-09       Impact factor: 3.320

3.  The association of VDR polymorphisms and type 2 diabetes in older people living in community in Santiago de Chile.

Authors:  Bárbara Angel; Lydia Lera; Carlos Márquez; Cecilia Albala
Journal:  Nutr Diabetes       Date:  2018-05-25       Impact factor: 5.097

4.  Abdominal obesity and low physical activity are associated with insulin resistance in overweight adolescents: a cross-sectional study.

Authors:  Claudia-María Velásquez-Rodríguez; Marcela Velásquez-Villa; Leidy Gómez-Ocampo; Juliana Bermúdez-Cardona
Journal:  BMC Pediatr       Date:  2014-10-10       Impact factor: 2.125

5.  Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for Homeostasis Model Assessment-2 Insulin Resistance: A Report from a Venezuelan Population.

Authors:  Valmore Bermúdez; Joselyn Rojas; María Sofía Martínez; Vanessa Apruzzese; Mervin Chávez-Castillo; Robys Gonzalez; Yaquelín Torres; Juan Salazar; Luis Bello; Roberto Añez; Maricarmen Chacín; Alexandra Toledo; Mayela Cabrera; Edgardo Mengual; Raquel Ávila; Freddy Pachano; José López-Miranda
Journal:  Int Sch Res Notices       Date:  2014-10-29

6.  Prevalence of Non-responders for Glucose Control Markers after 10 Weeks of High-Intensity Interval Training in Adult Women with Higher and Lower Insulin Resistance.

Authors:  Cristian Álvarez; Rodrigo Ramírez-Campillo; Robinson Ramírez-Vélez; Mikel Izquierdo
Journal:  Front Physiol       Date:  2017-07-06       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.